Synthesis of L-(+)-3-(3-hydroxy-4-pivaloyloxybenzyl)-2,5-diketomorpholine as potential prodrug of L-dopa

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 12, 2000, Pages 1385-1388

  Cingolani, Gian Mario ^a   Di Stefano, Antonio ^b   Mosciatti, Barbara ^a   Napolitani, Fabrizio ^a   Giorgioni, Gianfabio ^a   Ricciutelli, Massimo ^a   Claudi, Francesco ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; MORPHOLINE DERIVATIVE;

ARTICLE; DRUG MECHANISM; DRUG STABILITY; DRUG SYNTHESIS; ENZYME STABILITY; HUMAN; LIPOPHILICITY; NONHUMAN; RAT; STRUCTURE ANALYSIS;

ANIMALS; ANTIPARKINSON AGENTS; HALF-LIFE; HUMANS; LEVODOPA; MORPHOLINES; PRODRUGS; RATS;

EID: 0034686406     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00249-3     Document Type: Article

References (12)

1. Gundert-Remy U., Hildebrand R., Stiehl A., Weber E., Zurcher G., Da Prada M. Eur. J. Clin. Pharmacol. 25:1983;69.
2. Da Prada M., Keller H.H., Pieri L., Kettler L., Haefely W.E. Experentia. 40:1984;1165.
3. Garzon-Aburbeh A., Poupaert J.H., Claesen M., Dumont P. J. Med. Chem. 29:1986;687.
4. Bodor N., Sloan K.B., Higuchi T. J. Med. Chem. 20:1977;1435.
5. Ihara M., Nakajima S., Hisaka A., Tsuchiya Y., Sakuma Y., Suzuki H., Kitani K., Yano M. J. Pharm. Sci. 79:1990;703.
6. Wang H., Lee J., Tsai M., Lu H., Hsu W. Bioorg. Med. Chem. Lett. 5:1995;2195.
7. Ihara M., Tsuchiya Y., Sawasaki Y., Hisaka A., Takehana H., Tomimoto K., Yano M. J. Pharm. Sci. 78:1989;525.
8. 3C). MS m/e 309 (M+).
9. Yalkowsky, S. H., Morzowich, W. In Drug Design, J. Ariens, Ed.; Academic: New York, 1980; Vol. IX, p 121.
10. Farghaly A.O. Eur. J. Med. Chem. 33:1998;123.
11. Welch R.M., Brown A., Ravitch J., Dahl R. Clin. Pharmacol. Ther. 58:1995;132.
12. Wu G., Furlanut M. Il Farmaco. 54:1999;188.